AU
MEDP icon

AlphaGrep UK’s Medpace MEDP Stock Holding History

AlphaGrep UK’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$466K Sell
880
-482
-35% -$222K 0.14% 264
2026
Q1 		$654K Sell
1,362
-413
-23% -$211K 0.19% 125
2025
Q4 		$997K Buy
+1,775
New +$1.01M 0.33% 36

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

AlphaGrep UK's MEDP Position: Q2 2026 in Review

AlphaGrep UK reduced its Medpace (MEDP) stake by 35% in Q2 2026, selling an estimated $222K and leaving 880 shares worth $466K. The position accounts for 0.14% of the portfolio, ranked #264.

AlphaGrep UK first reported a position in MEDP in Q4 2025 and has held it in 3 quarters since. The position peaked at $997K in Q4 2025. 661 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • AlphaGrep UK held 880 shares of Medpace worth $466K as of Q2 2026.
  • AlphaGrep UK sold 482 Medpace shares in Q2 2026, an estimated $222K.
  • Medpace made up 0.14% of AlphaGrep UK's portfolio in Q2 2026, its #264 holding.
  • AlphaGrep UK first reported a position in Medpace in Q4 2025 and has held it in 3 quarters since.
  • AlphaGrep UK's Medpace position peaked at $997K in Q4 2025.
  • 661 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on AlphaGrep UK's 13F filing for Q2 2026, filed 14 Aug 2026.